Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood

被引:112
作者
Eda, Hiroyuki [1 ]
Zhang, Jian [1 ]
Keith, Robert H. [1 ]
Michener, Marshall [1 ]
Beidler, David R. [1 ]
Monahan, Joseph B. [1 ]
机构
[1] Pfizer Inc, St Louis Labs, Discovery Biol, Global Res & Dev, Chesterfield, MO 63017 USA
关键词
M-CSF; IL-34; Human whole blood; Chemokine; MCP-1/CCL2; MONOCYTE CHEMOATTRACTANT PROTEIN-1; COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; CHEMOTACTIC PROTEIN-1; FACTOR-I; RHEUMATOID-ARTHRITIS; TYPE-2; MACROPHAGES; JOINT INFLAMMATION; MESSENGER-RNA; M-CSF;
D O I
10.1016/j.cyto.2010.08.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The aim of this study is to investigate if macrophage-colony stimulating factor (M-CSF) or interleukin-34 (IL-34) induces cytokines or chemokines using human whole blood (HWB) and if an M-CSF- or IL-34-induced cytokine or chemokine production from HWB is inhibited by soluble M-CSF receptor or c-FMS kinase inhibitors. Among eight cytokines or growth factors tested, only IL-6 level was increased by up to 6-fold by M-CSF or IL-34 in HWB. In contrast, chemokine levels (IP-10/CXCL10, IL-8/CXCL8, and MCP-1/CCL2) were dramatically increased by M-CSF or IL-34 in HWB while exhibiting a large variation among donors. Variability of the MCP-1 signal induced by M-CSF or IL-34 was relatively less among donors compared to the IP-10 and IL-8 signals. The elevation of these chemokine levels was significantly decreased by soluble M-CSF receptor, indicating the elevation of these chemokines was mediated by M-CSF or IL-34. Furthermore, GW2580, a c-FMS kinase inhibitor, inhibited the induction of MCP-1 by M-CSF or IL-34 in a concentration dependent manner. These indicate MCP-1 is the most appropriate chemokine target for a chemokine release assay to evaluate the potency of c-FMS kinase inhibitors and MCP-1 release assay using HWB would be useful, relevant tool for translational pharmacology of c-FMS kinase inhibitors. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 48 条
[1]
Effects of macrophage colony-stimulating factor (M-CSF) on lipopolysaccharide (LPS)-induced mediator production from monocytes in vitro [J].
Asakura, E ;
Hanamura, T ;
Umemura, A ;
Yada, K ;
Yamauchi, T ;
Tanabe, T .
IMMUNOBIOLOGY, 1996, 195 (03) :300-313
[2]
Regulation of myeloid development and function by colony stimulating factors [J].
Barreda, DR ;
Hanington, PC ;
Belosevic, M .
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2004, 28 (05) :509-554
[3]
Bischof RJ, 2000, CLIN EXP IMMUNOL, V119, P361
[4]
Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line [J].
Biswas, P ;
Delfanti, F ;
Bernasconi, S ;
Mengozzi, M ;
Cota, M ;
Polentarutti, N ;
Mantovani, A ;
Lazzarin, A ;
Sozzani, S ;
Poli, G .
BLOOD, 1998, 91 (01) :258-265
[5]
SD0006: A Potent, Selective and Orally Available Inhibitor of p38 Kinase [J].
Burnette, Barry L. ;
Selness, Shaun ;
Devraj, Raj ;
Jungbluth, Gail ;
Kurumbail, Ravi ;
Stillwell, Loreen ;
Anderson, Gary ;
Mnich, Stephen ;
Hirsch, Jeffrey ;
Compton, Robert ;
De Ciechi, Pamela ;
Hope, Heidi ;
Hepperle, Michael ;
Keith, Robert H. ;
Naing, Win ;
Shieh, Huey ;
Portanova, Joseph ;
Zhang, Yan ;
Zhang, Jian ;
Leimgruber, Richard M. ;
Monahan, Joseph .
PHARMACOLOGY, 2009, 84 (01) :42-60
[6]
Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144
[7]
Colony-stimulating factor-1 in immunity and inflammation [J].
Chitu, V ;
Stanley, ER .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :39-48
[8]
Effects of the cFMS kinase inhibitor 5-(3-methoxy-4-((4-methoxybenzyl) oxy)benzyl)pyrimidine-2,4-diamine (GW2580) in normal and arthritic rats [J].
Conway, James G. ;
Pink, Heather ;
Bergquist, Mandy L. ;
Han, Bajin ;
Depee, Scott ;
Tadepalli, Sarva ;
Lin, Peiyuan ;
Crumrine, R. Christian ;
Binz, Jane ;
Clark, Richard L. ;
Selph, Jeffrey L. ;
Stimpson, Stephen A. ;
Hutchins, Jeff T. ;
Chamberlain, Stanley D. ;
Brodie, Thomas A. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 326 (01) :41-50
[9]
Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580 [J].
Conway, JG ;
McDonald, B ;
Parham, J ;
Keith, B ;
Rusnak, DW ;
Shaw, E ;
Jansen, M ;
Lin, PY ;
Payne, A ;
Crosby, RM ;
Johnson, JH ;
Frick, L ;
Lin, MHJ ;
Depee, S ;
Tadepalli, S ;
Votta, B ;
James, I ;
Fuller, K ;
Chambers, TJ ;
Kull, FC ;
Chamberlain, SD ;
Hutchins, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (44) :16078-16083
[10]
Synovial macrophage-osteoclast differentiation in inflammatory arthritis [J].
Danks, L ;
Sabokbar, A ;
Gundle, R ;
Athanasou, NA .
ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 (10) :916-921